For the quarter ended September 2025, Globus Medical (GMED) reported revenue of $769.05 million, up 22.9% over the same period last year. EPS came in at $1.18, compared to $0.83 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $733.45 million, representing a surprise of +4.85%. The company delivered an EPS surprise of +49.37%, with the consensus EPS estimate being $0.79.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Globus Medical performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Geographic Revenues- International: $151.42 million versus $144.37 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +16.6% change.
- Geographic Revenues- United States: $617.63 million versus the three-analyst average estimate of $589.84 million. The reported number represents a year-over-year change of +24.6%.
- Net Sales by Product Category- Enabling Technologies: $28.04 million versus the three-analyst average estimate of $40.23 million. The reported number represents a year-over-year change of -26.8%.
- Net Sales by Product Category- Musculoskeletal Solutions: $741.01 million versus the three-analyst average estimate of $693.98 million. The reported number represents a year-over-year change of +26.2%.
View all Key Company Metrics for Globus Medical here>>>
Shares of Globus Medical have returned +1.8% over the past month versus the Zacks S&P 500 composite's +1.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Globus Medical, Inc. (GMED): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
